metformin has been researched along with Hemangioma in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Hemangioma: A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 52-year-old man with a 9-year history of hepatic hemangioma was treated with the anti-diabetic drug metformin, resulting in complete remission of the tumor." | 7.85 | A case of liver hemangioma with markedly reduced tumor size after metformin treatment: a case report. ( Okumura, T; Ono, M; Sawada, K, 2017) |
| "A 52-year-old man with a 9-year history of hepatic hemangioma was treated with the anti-diabetic drug metformin, resulting in complete remission of the tumor." | 3.85 | A case of liver hemangioma with markedly reduced tumor size after metformin treatment: a case report. ( Okumura, T; Ono, M; Sawada, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ono, M | 1 |
| Sawada, K | 1 |
| Okumura, T | 1 |
1 other study available for metformin and Hemangioma
| Article | Year |
|---|---|
A case of liver hemangioma with markedly reduced tumor size after metformin treatment: a case report.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Hemangioma; Humans; Liver Neoplasms; Magnetic Resona | 2017 |